Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Protzer

Showing results (241-250 of 308) with videos related to

Pageof 31
Sort By:
ACS Applied Materials & Interfaces|February 1, 2023
Adsorption and Inactivation of SARS-CoV-2 on the Surface of Anatase TiO<sub>2</sub>(101)Mona Kohantorabi, Michael Wagstaffe, Marcus Creutzburg, et al.
Journal of Medical Virology|June 20, 2024
Hybrid immunity by two COVID-19 mRNA vaccinations and one breakthrough infection provides a robust and balanced cellular immune response as basic immunity against severe acute respiratory syndrome coronavirus 2Giovanni Almanzar, Kimia Koosha, Tim Vogt, et al.
Cell|April 21, 2015
Immunosurveillance of the liver by intravascular effector CD8(+) T cellsLuca G Guidotti, Donato Inverso, Laura Sironi, et al.
Respiratory Research|April 24, 2021
SARS-CoV-2 serology increases diagnostic accuracy in CT-suspected, PCR-negative COVID-19 patients during pandemicJochen Schneider, Hrvoje Mijočević, Kurt Ulm, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 5, 2022
Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B<sub>2</sub> receptor antagonismConstanze A Jakwerth, Martin Feuerherd, Ferdinand M Guerth, et al.
Cell Reports|September 4, 2012
TNF-induced target cell killing by CTL activated through cross-presentationDirk Wohlleber, Hamid Kashkar, Katja Gärtner, et al.
Emerging Infectious Diseases|February 23, 2022
Infection Control Measures and Prevalence of SARS-CoV-2 IgG among 4,554 University Hospital Employees, Munich, GermanyJohanna Erber, Verena Kappler, Bernhard Haller, et al.
Ebiomedicine|November 10, 2024
Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responsesSebastian Einhauser, Claudia Asam, Manuela Weps, et al.
Frontiers in Immunology|June 12, 2026
Helminth infection modulates the immunogenicity of COVID-19 vaccines in mice without compromising protective efficacyJinpeng Su, Youssef Hamway, Daniele Mistretta, et al.
Gastroenterology|September 30, 2015
Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without CytolysisYuchen Xia, Daniela Stadler, Julie Lucifora, et al.
Pageof 31

Showing results (241-250 of 308) with videos related to

Sort By:
Pageof 31
ACS Applied Materials & Interfaces|February 1, 2023
Adsorption and Inactivation of SARS-CoV-2 on the Surface of Anatase TiO<sub>2</sub>(101)Mona Kohantorabi, Michael Wagstaffe, Marcus Creutzburg, et al.
Journal of Medical Virology|June 20, 2024
Hybrid immunity by two COVID-19 mRNA vaccinations and one breakthrough infection provides a robust and balanced cellular immune response as basic immunity against severe acute respiratory syndrome coronavirus 2Giovanni Almanzar, Kimia Koosha, Tim Vogt, et al.
Cell|April 21, 2015
Immunosurveillance of the liver by intravascular effector CD8(+) T cellsLuca G Guidotti, Donato Inverso, Laura Sironi, et al.
Respiratory Research|April 24, 2021
SARS-CoV-2 serology increases diagnostic accuracy in CT-suspected, PCR-negative COVID-19 patients during pandemicJochen Schneider, Hrvoje Mijočević, Kurt Ulm, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 5, 2022
Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B<sub>2</sub> receptor antagonismConstanze A Jakwerth, Martin Feuerherd, Ferdinand M Guerth, et al.
Cell Reports|September 4, 2012
TNF-induced target cell killing by CTL activated through cross-presentationDirk Wohlleber, Hamid Kashkar, Katja Gärtner, et al.
Emerging Infectious Diseases|February 23, 2022
Infection Control Measures and Prevalence of SARS-CoV-2 IgG among 4,554 University Hospital Employees, Munich, GermanyJohanna Erber, Verena Kappler, Bernhard Haller, et al.
Ebiomedicine|November 10, 2024
Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responsesSebastian Einhauser, Claudia Asam, Manuela Weps, et al.
Frontiers in Immunology|June 12, 2026
Helminth infection modulates the immunogenicity of COVID-19 vaccines in mice without compromising protective efficacyJinpeng Su, Youssef Hamway, Daniele Mistretta, et al.
Gastroenterology|September 30, 2015
Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without CytolysisYuchen Xia, Daniela Stadler, Julie Lucifora, et al.
Pageof 31